Terns Pharmaceuticals Stock Quote TERN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

8.485

Bid

8.38

Ask

9.06

Volume

877,666

8.3434 Day's Range 8.8305

3.26 52 Week Range 10.03

Market Cap

562.044M

Previous Close

8.69

Open

8.55

Last Trade

8.89

Last Trade Time

Financial Volume

$ 7,458,673

VWAP

8.4983

Average Volume (3m)

1,122,356

Shares Outstanding

64,677,145

Dividend Yield

PE Ratio

-6.08

Earnings Per Share (EPS)

-1.39

Revenue

Net Profit

-90.21M

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ternspharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Terns Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TERN. The last closing price for Terns Pharmaceuticals was $8.69. Over the last year, Terns Pharmaceuticals shares have traded in a share price range of $ 3.26 to $ 10.03.

Terns Pharmaceuticals currently has 64,677,145 shares outstanding. The market capitalization of Terns Pharmaceuticals is $562.04 million. Terns Pharmaceuticals has a price to earnings ratio (PE ratio) of -6.08.

Overall Flow

Bullish

Net Premium

251k

Calls / Puts

100.00%

Buys / Sells

50.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation

FOSTER CITY, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.015	-0.176470588235	8.5	10.03	8.26	1604441	9.50616979	CS
4	1.475	21.0413694722	7.01	10.03	6.38	1337950	8.10037874	CS
12	3.805	81.3034188034	4.68	10.03	4.62	1122356	7.13741013	CS
26	3.305	63.8030888031	5.18	10.03	4.32	986910	6.84666434	CS
52	0.685	8.78205128205	7.8	10.03	3.26	772822	6.45726513	CS
156	-0.445	-4.98320268757	8.93	14.0435	1.45	440657	7.10990654	CS
260	-8.465	-49.9410029499	16.95	28.36	1.45	401249	7.69893569	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SERVServe Robotics Inc	$ 7.51 (185.55%)	262.73M
AUGXAugmedix Inc	$ 2.27 (147.71%)	21.87M
XCURExicure Inc	$ 0.5351 (76.02%)	14.02M
PSNLPersonalis Inc	$ 3.83 (56.33%)	22.76M
MDBHMDB Capital Holdings LLC	$ 10.675 (37.21%)	126.13k
SPWRSunPower Corporation	$ 0.6735 (-55.40%)	119.98M
HYZNHyzon Motors Inc	$ 0.149 (-47.54%)	23.37M
MEDSTRxADE Health Inc	$ 14.92 (-33.45%)	204.34k
SILOSilo Pharma Inc	$ 2.50 (-27.95%)	11.12M
KITTNauticus Robotics Inc	$ 0.0935 (-27.46%)	26.52M
SERVServe Robotics Inc	$ 7.51 (185.55%)	262.73M
NVDANVIDIA Corporation	$ 117.93 (-2.61%)	206.41M
SXTP60 Degrees Pharmaceuticals Inc	$ 0.2602 (5.77%)	202.14M
SQQQProShares UltraPro Short QQQ	$ 8.46 (2.79%)	184.21M
SPWRSunPower Corporation	$ 0.6735 (-55.40%)	119.98M